HCW9218
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HCW9218, covering 2025-01-01 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: HCW9218 for Advanced Pancreatic Cancer [Phase 1, Phase 2]